Advanced search
Publication Cover
Journal of Sex Education and Therapy Volume 24, 1999 - Issue 1-2: Researching HIV/STD Risk Behavior: Implications for Prevention
Journal homepage
8
Views
13
CrossRef citations to date
0
Altmetric
Original Articles

Behavioral Practices Regarding Combination Therapies for HIV/AIDS

Marya GwadzUniversity of California, Los Angeles
,
Roberto De VogliWorld Health Organization
,
Mary Jane Rotheram-BorusUniversity of California, Los Angeles
,
Marie M. DiazUniversity of California, Los Angeles
,
Tri CisekUniversity of California, Los Angeles
,
Nionne B. JamesAIDS Service Center
&
Nim TottenhamUniversity of California, Los Angeles
 show all
Pages 81-88 | Published online: 21 Jan 2015

  • Bachiller, P., Rodriguez, R, Liceaga, A. G., Iribarren, J. A., Ollo-quiegui, E., Ariz, M. C., Odriozola, B., & Barcia, M. J. (1998). Adherence to antiretroviral therapy in HIV-infected patients. Poster session presented at the 12th World AIDS Conference. Geneva, Switzerland.
  • Balestra, P., Ferri, F., Galgani, S., Narciso, P., Pellicelli, A., Tozzi, V., Zaccarelli, M., & Visco, G. (1996). Clinical, psychological, and behavioral characteristics of HIV patients reporting low compliance to treatments. Poster session presented at the XIth International Conference on AIDS. Vancouver, British Columbia, Canada.
  • Becker, M. H., & Maiman, L. A. (1982). Strategies for increasing patient compliance. Journal of Community Health, 6, 113–135.
  • Brettle, R. P., Wilson, A., Povey, S., Morris, S., Morgan, R., Leen, C. L., Hutchinson, S., Lewis, S., & Gore, S. (1998). Combination therapy for HIV: The effect on inpatient activity, morbidity and mortality in a cohort of patients. International Journal of STD and AIDS, 9, 80–87.
  • Broers, B., Morabia, A., & Hirschel, B. (1994). A cohort study of drug users' compliance with zidovudine treatment. Archives of Internal Medicine, 154, 1121–1127.
  • Centers for Disease Control and Prevention. (1998). Report of the NIH panel to define principles of therapy of HIV infection and guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. Morbidity and Mortality Weekly Report, 47, 1–91.
  • Chesney, M. A., Chambers, D. B., & Kahn, J. O. (1997). Risk behavior for HIV infection in participants in preventive HIV vaccine trials: A cautionary note. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 16, 266–271.
  • Chow, R., Chin, T., Fong, I. W., & Bendayan, R. (1993). Medication use patterns in HIV-positive patients. Canadian Journal of Hospital Pharmacy, 46, 171–175.
  • Collier, A. C., Coombs, R. W., Schoenfeld, D. A., Bassett, R. L., Timpone, J., Baruch, A., Jones, M., Facey, K., Whitacre, C., McAuliffe, V. J., Friedman, H. M., Merigan, T. C., Reichman, R. C., Hooper, C., & Corey, L. (1996). Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine: AIDS Clinical Trials Group. New England Journal of Medicine, 334, 1011–1017.
  • Cummings, K. M., Kirscht, J. P., Binder, L. R., & Godley, A. J. (1982). Determinants of drug treatment maintenance among hypertensive persons in inner city Detroit. Public Health Reports, 97, 99–106.
  • Dilley, J. W., Woods, W. J., & McFarland, W. (1997). Are advances in treatment changing views about high-risk sex? New England Journal of Medicine, 337, 501–502.
  • Ehrhardt, A. A., Feldman, J. F., Rosen, L. R., Meyer-Bahlburg, H. F., Gruen, R., Veridiano, N. P., Endicott, J., & Cohen, P. (1987). Psychopathology in prenatally DES-exposed females: Current and lifetime adjustment. Psychosomatic Medicine, 49, 183–196.
  • Eldred, L. (in press). Adherence in the era of protease inhibitors. Journal of AIDS Research.
  • Eldred, L., Wu, A. W., Chaisson, R. E., & Moore, R. D. (1998). Adherence to antiretroviral and pneumocystis prophylaxis in HIV disease. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 18, 117–125.
  • Eraker, S., Kirscht, J. P., & Becker, M. H. (1984). Understanding and improving patient compliance. Annals of Internal Medicine, 100, 258–268.
  • Friedland, G. H. (1997). Adherence: The Achilles' heel of highly active antiretroviral therapy. Improving the Management of HIV Disease, 5, 13–15.
  • Geletko, S. M., Ballard, C. R., & Mathews, W. C. (1995). Health beliefs and discontinuation of zidovudine therapy. American Journal of Health-System Pharmacy, 52, 505–507.
  • Greenberg, R. N. (1984). Overview of patient compliance with medication dosing: A literature review. Clinical Therapeutics, 6, 592–599.
  • Gulick, R. M., Mellors, J. W., Havlir, D., Eron, J. J., Gonzalez, C., McMahon, D., Richman, D. D., Valentine, F. T., Jonas, L., Meibohm, A., Emini, E. A., & Chodakewitz, J. A. (1997). Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. New England Journal of Medicine, 337, 734–739.
  • Gwadz, M. (Sept., 1998). Adolescent HIV Prevention: What Works and What Doesn't. Presented at the Schweitzer Seminar on HIV/AIDS, Ulaan Baator, Mongolia.
  • Harrison, K., Vlahov, D., Jones, K., Charron, K., & Clements, M. L. (1995). Medical eligibility, comprehension of the consent process, and retention of injection drug users recruited for an HIV vaccine trial. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 10, 386–390.
  • Herek, G. M. & Capitanio, J. P. (1993). Public reactions to AIDS in the United States: A second decade of stigma. American Journal of Public Health, 83, 574–577.
  • Ho, D. D. (1996). Viral counts count in HIV infection. Science, 272, 1124–1125.
  • Katzenstein, D. A. (1997). Antiretroviral therapy for human immunodeficiency virus infection in 1997. Western Journal of Medicine, 166, 319–325.
  • The Measurement Group. (1997). Adherence to protease inhibitor combination therapy among youth: A report from a focus group on issues for youth living with HIV. Culver City, CA.
  • Mechanic, D. (1991). Adolescents at risk: New directions. Journal of Adolescent Health, 12, 638–643.
  • Ostrop, N., Hallett, K., & Gill, M. J. (1998). Patient adherence to antiretroviral therapy. Poster session presented at the 12th World Conference on AIDS. Geneva, Switzerland.
  • Palella, F. Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., Aschman, D. J., & Holmberg, S. D. (1998). Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. New England Journal of Medicine, 338(13), 853–60.
  • Perelson, A. S., Neumann, A. U., Markowitz, M., Leonard, J. M., & Ho, D. D. (1996). HIV-1 dynamics in vivo: Virion clearance rate, infected cell life-span, and viral generation time. Science, 271, 1582–1586.
  • Sackett, D. L., & Snow, J. S. (1979). The magnitude of compliance and noncompliance. In R. B. Haynes, D. W. Taylor, & D. L. Sackett (Eds.), Compliance in health care (pp. 11–22). Baltimore, MD: Johns Hopkins University Press.
  • Samet, J. H., Libman, H., Steger, K. A., Dhawan, R., Chen, J., Shevitz, A. H., Dewees-Durk, R., Levenson, S., Kufe, D., & Craven, D. E. (1992). Compliance with zidovudine therapy in patients infected with human immunodeficiency virus type I: A cross-sectional study in a municipal hospital clinic. American Journal of Medicine, 92, 495–502.
  • Singh, N., Squier, C., Sivek, C., Wagener, M., Nguyen, M. H., & Yu, V. L. (1996). Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: Prospective assessment with implications for enhancing compliance. AIDS Care, 8, 261–269.
  • Staszewski, S., Miller, V., Rehmet, S., Stark, T., De Cree, J., De Brabander, M., Peeters, M., Andries, K., Moeremans, M., De Raeymaeker, M., Pearce, G., Van den Broeck, R., Verbiest, W., & Stoffels, P. (1996). Virological and immunological analysis of a triple combination pilot study with lo viride, lamivudine and zidovudine in HIV-1-infected patients. AIDS, 10, F1–F7.
  • Taylor, D. W., Sackett, D. L., Haynes, R. B., Johnson, A. L., Gibson, E. S., & Roberts, R. S. (1978). Compliance with antihypertensive drug therapy. Annals of the New York Academy of Sciences, 304, 390–403.
  • Zax, M., Marsey, R., & Biggs, C. F. (1961). Demographic characteristics of alcoholic outpatients and the tendency to remain in treatment. Quarterly Journal of Studies on Alcohol, 22, 98–105.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.